5% of global net sale for 10 years I just hope we can use this data to get a refractory use approval in Canada (NOC/c). Since it has very few 1st time patients in these two trials, I don't see them useful for 1st line use application, unless HC would accept "implied" results.
I hope Graeme had some sort of a secret node from HC before we offered to buy these data. Otherwise, we might have thrown away 5% of our future for nothing again. Well, maybe the right to the control of NR about Urocidin again. (wink, wink)
We must ask him WHAT and HOW we plan to use these data we just bought on Jan 10th.